Monte Rosa Therapeutics Inc (GLUE)
SBC to Revenue
66.57%
Quarterly · Period ending:
GLUE SBC to Revenue
Latest reported66.57%period ending
Latest reported66.57%period ending
GLUE Quarterly SBC/Revenue (0.00% → 66.57%)
Latest values, visible window
High-resolution chart · PNG
GLUE sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 66.57% | |
| 141.3064% | |
| 154.9443% | |
| 34.1792% | |
| 21.1003% | |
| 6.2382% | |
| 7.3689% | |
| 46.4627% | |
| 95.8892% | |
| 457.9887% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |